Results
|
|
1.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
2.
|
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
- Fries, Melissa
- Lynce, Filipa
Year: 2015
Citation: - Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
|
|
|
3.
|
|
|
|
4.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
|
|
5.
|
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors:
- Blackburn, Matthew J
- Lynce, Filipa
Year: 2018
Citation: - Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H
|
|
|
6.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
|
7.
|
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer. MedStar authors:
- Gallagher, Christopher
- Kamugisha, Lois
- Lynce, Filipa
- Mohebtash, Mahsa
- Saleh, Mervat
Year: 2018
Citation: - Contemporary Clinical Trials Communications. 10:190-192, 2018 Jun.
Institution:
- MedStar Good Samaritan Hospital
- MedStar Union Memorial Hospital
- Washington Cancer Institute
Medline publication type:
All authors: - Abu-Khalaf M, Cai L, Dilawari A, Gallagher C, Hahn O, Isaacs C, Kamugisha L, Lynce F, Mohebtash M, Pohlmann P, Saleh M, Shajahan-Haq A
|
|
|
8.
|
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J
|
|
|
9.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
10.
|
Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors:
- Dilawari, Asma
- Gallagher, Christopher
- Khoury, Katia
- Lynce, Filipa
- Swain, Sandra M
Year: 2018
Department: - MedStar Georgetown University Hospital Residents
All authors: - Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F.
|
|
|
11.
|
|
|
|
12.
|
Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors:
- Dilawari, Asma
- Gallagher, Christopher
- Khoury, Katia
- Lynce, Filipa
- Swain, Sandra M
Year: 2019
Department: - MedStar Georgetown University Hospital Residents
All authors: - Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F.
|
|
|
13.
|
Cardiac function in BRCA1/2 mutation carriers with a history of breast cancer treated with anthracyclines MedStar authors:
- Barac, Ana
- Herbolsheimer, Pia M
- Isaacs, C
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Swain, Sandra M
Year: 2015
Department: - MedStar Heart and Vascular Institute
All authors: - Barac A, Lynce F, Mete M, Herbolsheimer P, Nunes R, Swain S, Warren R, Isaacs C
|
|
|
14.
|
Video intervention increases participation of black breast cancer patients in therapeutic trials. MedStar authors:
- Gallagher, Christopher
- Herbolsheimer, Pia M
- Lee, Young
- Lynce, Filipa
- Mete, Mihriye
- Mohapatra, Avani
- Mohebtash, Mahsa
- Newman, Antoinette F
- Nunes, Raquel
- Omogbehin, Adedamola
- Ottaviano, Yvonne
- Randolph-Jackson, Pamela
- Robinson, Brandi N
- Swain, Sandra M
- Tefera, Eshetu
Year: 2017
Citation: - NPJ Breast Cancer. 3:36, 2017
Institution:
- MedStar Franklin Square Medical Center
- MedStar Harbor Hospital
- MedStar Health Research Institute
- MedStar Union Memorial Hospital
- Washington Cancer Institute
Medline publication type:
All authors: - Brown R, Dilawari A, Gallagher C, Herbolsheimer P, Lee Y, Lynce F, Mete M, Mohapatra A, Mohebtash M, Newman AF, Nunes R, Omogbehin A, Ottaviano Y, Pohlmann PR, Randolph-Jackson P, Robinson BN, Swain SM, Tefera E
|
|
|
15.
|
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. MedStar authors:
- Lynce, Filipa
- Schlam, Ilana
Year: 2021
Citation: - Journal of Genetic Counseling. 30(2):383-393, 2021 04.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahn J, Campos C, Denduluri N, Dutil J, Friedman S, Geng X, Graves KD, Isaacs C, Lynce F, Nahleh Z, Peshkin BN, Ricker C, Rodriguez P, Schlam I
|
|
|
16.
|
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Gallagher, Christopher
- Hofmeyer, Mark
- Lynce, Filipa
- Srichai, Monvadi B
- Swain, Sandra M
Year: 2021
Citation: - Breast Cancer Research & Treatment. 2021 Jan 05
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Asch F, Barac A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Khoury K, Lynce F, Nunes R, Pohlmann PR, Smith KL, Srichai MB, Swain SM, Tan M, Warren R, Yu AF
|
|
|
17.
|
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
- Blackburn, Matthew J
- Chitalia, Ami
- Dilawari, Asma
- Gallagher, Christopher
- Lynce, Filipa
- Mohebtash, Mahsa
- Tiwari, Shruti R
Year: 2021
Citation: - Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
- MedStar Franklin Square Cancer Center at Loch Raven Campus
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Hematology & Oncology Fellowship
- Hematology and Oncology
Medline publication type:
All authors: - Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
|
|
|
18.
|
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. MedStar authors:
- Gallagher, Christopher
- Lynce, Filipa
- Ottaviano, Yvonne
Year: 2021
Citation: - Clinical Cancer Research. 27(21):5810-5817, 2021 11 01.
Institution:
- MedStar Franklin Square Medical Center
- Washington Cancer Institute
Medline publication type:
All authors: - Althouse SK, Ballinger TJ, Bauchle A, Dong Z, Gallagher C, Liu JY, Lynce F, Masters AR, Miller KD, Ottaviano YL, Perkins SM, Sardesai SD, Schneider BP, Storniolo AM, Stratford RE Jr, Thomas A, Zhang JT
|
|
|
19.
|
Obesity in adult lymphoma survivors. MedStar authors:
- Catlett, Joseph
- Lynce, Filipa
- Malkovska, Vera
- Pehlivanova, Marieta
Citation: - Leukemia & Lymphoma. 53(4):569-74, 2012 Apr.
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Catlett J, Lynce F, Malkovska V, Pehlivanova M
|
|
|
20.
|
Avastin withdrawal symptoms. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Citation: - Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Editorial
- Research Support, Non-U.S. Gov't
|
|
|
21.
|
|
